Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection

PLoS Neglected Tropical Diseases

Volumn 2, Issue 10, 2008, Pages

  Cardoso, Fernanda C ^a   Macedo, Gilson C ^a   Gava, Elisandra ^a   Kitten, Gregory T ^a   Mati, Vitor L ^a   de Melo, Alan L ^a   Caliari, Marcelo V ^a   Almeida, Giulliana T ^b   Venancio, Thiago M ^b,c   Verjovski Almeida, Sergio ^b   Oliveira, Sergio C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; MEMBRANE ANTIGEN; MICROORGANISM PROTEIN; PROTEIN ANTIBODY; PROTEIN SM29; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN SM29; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HELMINTH ANTIBODY; HELMINTH PROTEIN; IMMUNOGLOBULIN G; PARASITE ANTIGEN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; DRUG ISOLATION; FEMALE; GENE EXPRESSION REGULATION; LIVER GRANULOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMULUM; TH1 CELL; UPREGULATION; VACCINE PRODUCTION; WORM EGG; ANIMAL; BLOOD; C57BL MOUSE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; LUNG; MALE; MOUSE MUTANT; PARASITOLOGY; SCHISTOSOMIASIS MANSONI;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; FEMALE; HELMINTH PROTEINS; HUMANS; IMMUNOGLOBULIN G; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TH1 CELLS; VACCINES;

EID: 56149122056     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000308     Document Type: Article

References (44)

1. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139.
2. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: Systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
3. King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helmintic infection: A meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
4. Harder A (2002) Chemotherapeutic approaches to schistosomes: Current knowledge and outlook. Parasitol Res 88: 395-397.
5. Bergquist NR (1998) Schistosomiasis vaccine development: Progress and Prospects. Mem Inst Oswaldo Cruz 93: 95-101.
6. Bergquist NR (2002) Schistosomiasis: From risk assessment to control. Trends Parasitol 18: 309-314.
7. Chitsulo L, Loverde P, Engels D (2004) Schistosomiasis. Nat Rev Microbiol 2: 12-13.
8. Cardoso FC, Pacifico RNA, Mortara RA, Oliveira SC (2006) Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin Exp Immunol 144: 382-391.
9. Gobert GN, McInnes R, Moertel L, Nelson C, Jones MK, et al. (2006) Transcriptomics tool for the human Schistosoma blood flukes using microarray gene expression profiling. Exp Parasitol 114: 160-172.
10. Verjovski-Almeida S, Venancio TM, Oliveira KC, Almeida GT, DeMarco R (2007) Use of a 44k oligoarray to explore the transcriptome of Schistosoma mansoni adult worms. Exp Parasitol 117: 236-245.
11. Braschi S, Curwen RS, Ashton PD, Verjovski-Almeida S, Wilson A (2006) The tegument surface membranes of the human blood parasite Schistosoma mansoni: A proteomic analysis after differential extraction. Proteomics 6: 1471-1482.
12. Harrop R, Wilson RA (1993) Protein synthesis and release by cultured schistosomula of Schistosoma mansoni. Parasitology 107: 265-274.
13. Ramalho-Pinto FJ, Gazzinelli G, Howells RE, Mota-Santos TA, Figueiredo EA, et al. (1974) Schistosoma mansoni: Defined system for stepwise transformation of cercaria to schistosomule in vitro. Exp Parasitol 36: 360-372.
14. Fonseca CT, Brito CF, Alves JB, Oliveira SC (2004) IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine 22: 503-510.
15. Pacheco LG, Zucconi E, Mati VL, Garcia RM, Miyoshi A, et al. (2005) Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis. Acta Trop 95: 132-142.
16. Pacífico LG, Fonseca CT, Chiari L, Oliveira SC (2006) Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine. Immunobiology 211: 97-104.
17. Cardoso LS, Araujo MI, Goes AM, Pacifico LG, Oliveira RR, et al. (2007) Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb Cell Fact 6: 1-6.
18. DeMarco R, Oliveira KC, Venancio TM, Verjovski-Almeida S (2006) Gender biased differential alternative splicing patterns of the transcriptional cofactor CA150 gene in Schistosoma mansoni. Mol Biochem Parasitol 150: 123-131.
19. Verjovski-Almeida S, DeMarco R, Martins EAL, Guimaraães PEM, Ojopi EPB, et al. (2003) Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 35: 148-157.
20. Yang YH, Speed T (2002) Design issues for cDNA microarray experiments. Nat Rev Genet 3: 579-588.
21. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci U S A 98: 5116-5121.
22. Larsson O, Wahlestedt C, Timmons JA (2005) Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics 29: 126-129.
23. Wynn TA, Oswald IP, Eltoum IA, Caspar P, Lowenstein CJ, et al. (1994) Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 153: 5200-5209.
24. Coulson PS, Wilson RA (1997) Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes. Infect Immun 65: 42-48.
25. Hewitson JP, Hamblin PA, Mountford AP (2005) Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 27: 271-280.
26. Smythies LE, Coulson PS, Wilson RA (1992) Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J Immunol 149: 3654-3658.
27. Wilson RA, Coulson PS, Betis C, Dowking MA, Smythies LE (1996) Impaired Immunity and altered pulmonary response in mice with a disrupted interferon-γ receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 87: 275-282.
28. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
29. Wynn TA, Cheever AW (1995) Cytokine regulation of granuloma formation in schistosomiasis. Curr. Opin. Immunol 7: 505-511.
30. Sadler CH, Rutitzky LI, Stadecker MJ, Wilson RA (2003) IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni. Eur J Immunol 33: 880-888.
31. Hogg KG, Kumkate S, Mountford AP (2003) IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine. Int Immunol 15: 1451-1459.
32. Brito CF, Caldas IR, Coura Filho P, Correa-Oliveira R, Oliveira SC (2000) CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein. Scand J Immunol 51: 595-601.
33. Köster B, Hall MR, Strand M (1993) Schistosoma mansoni: immunoreactivity of human sera with the surface antigen Sm23. Exp Parasitol 77: 282-294.
34. Khalife J, Pierce RJ, Godin C, Capron A (1994) Molecular characterization of two Schistosoma mansoni proteins sharing common motifs with the vif protein of HIV-1. Parasitology 108: 533-542.
35. Fonseca CT, Pacífico LG, Barsante MM, Rassi T, Cassali GD, et al. (2006) Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone. Microbes Infect 8: 2509-2516.
36. Da'dara AA, Skelly PJ, Wang MM, Harn DA (2001) Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20: 359-369.
37. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12: 835-840.
38. Cook RM, Carvalho-Queiroz C, Wilding G, LoVerde PT (2004) Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun 72: 6112-6124.
39. Dinguirard N, Yoshino TP (2006) Potential role of a CD36-like class B scavenger receptor in the binding of modified low-density lipoprotein (acLDL) to the tegumental surface of Schistosoma mansoni sporocysts. Mol Biochem Parasitol 146: 219-230.
40. Venancio TM, DeMarco R, Almeida GT, Oliveira KC, Setubal JC, et al. (2007) Analysis of Schistosoma mansoni genes shared with Deuterostomia and with possible roles in host interactions. BMC Genomics. 2007 8: 407.
41. Vandewaa EA, Mills G, Chen GZ, Foster LA, Bennett JL (1989) Physiological role of HMG-CoA reductase in regulating egg production by Schistosoma mansoni. Am J Physiol 257: 618-625.
42. Dillon GP, Feltwell T, Skelton J, Coulson PS, Wilson RA, et al. (2008) Altered patterns of gene expression underlying the enhanced immunogenicity of radiation-attenuated schistosomes. PLoS Negl Trop Dis 2: E240. doi:10.1371/journal.pntd.0000240.
43. Cardoso FC, Pinho JMR, Azevedo V, Oliveira SC (2006) Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis. Genet Mol Res 5: 609-618.
44. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21: 225-242.